MARKET

RDNT

RDNT

Radnet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

18.92
-0.21
-1.10%
Closed 16:33 05/20 EDT
OPEN
19.38
PREV CLOSE
19.13
HIGH
19.66
LOW
18.17
VOLUME
407.08K
TURNOVER
--
52 WEEK HIGH
38.84
52 WEEK LOW
16.44
MARKET CAP
1.06B
P/E (TTM)
98.75
1D
5D
1M
3M
1Y
5Y
RadNet AI-based software solutions for breast, prostate cancers gets FDA clearance
RadNet (NASDAQ:RDNT) said it received U.S. FDA clearances for its DeepHeatlh Saige-DX mammography and Quantib Prostate 2.0 MRI artificial intelligence (AI) algorithms. The company said Saige-Dx is a software that
Seekingalpha · 6d ago
RadNet Artificial Intelligence Subsidiaries, DeepHealth And Quantib, Obtain FDA Clearance For Mammography And Prostate AI Tools
RadNet, Inc., (NASDAQ:RDNT) today announced that it has received FDA clearances for its DeepHealth Saige-DX™ mammography and Quantib® Prostate 2.0 MRI artificial intelligence (“AI”)
Benzinga · 05/16 10:09
RadNet Gets FDA Approval for Mammography, Prostate Artificial Intelligence Tools
MT Newswires · 05/16 06:30
RadNet To Participate in the White House Cancer Moonshot Goals Forum
LOS ANGELES, May 11, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), today announced that Howard Berger, M.D., the company’s President and Chief Executive Officer, will participate this week in the Cancer Moonshot Goals Forum, a consortium of healthc...
GlobeNewswire · 05/11 10:00
RadNet Q1 Earnings Exceed Expectations, Revises FY22 Guidance Levels Upwards
Benzinga · 05/09 13:24
RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates
RadNet (RDNT) delivered earnings and revenue surprises of -650% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 12:25
BRIEF-Radnet Reports First Quarter Financial Results
reuters.com · 05/09 10:24
RadNet Non-GAAP EPS of -$0.15 misses by $0.15, revenue of $341.8M beats by $8.34M
RadNet press release (NASDAQ:RDNT): Q1 Non-GAAP EPS of -$0.15 misses by $0.15. Revenue of $341.8M (+8.4% Y/Y) beats by $8.34M. For FY2022, the company expects revenue between $1.36B to $1.41B
Seekingalpha · 05/09 10:06
More
No Data
Learn about the latest financial forecast of RDNT. Analyze the recent business situations of Radnet through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

50.00%Strong Buy
25.00%Buy
25.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average RDNT stock price target is 33.00 with a high estimate of 40.00 and a low estimate of 28.00.
High40.00
Average33.00
Low28.00
Current 18.92
EPS
Actual
Estimate
-0.050.050.140.24
Q2 2021
Q3 2021
Q4 2021
  • 0
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 237
Institutional Holdings: 47.64M
% Owned: 84.74%
Shares Outstanding: 56.22M
TypeInstitutionsShares
Increased
72
2.92M
New
12
393.39K
Decreased
47
794.37K
Sold Out
16
672.01K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.40%
Healthcare Providers & Services
+1.60%
Key Executives
Chairman/Chief Executive Officer/President/Director
Howard Berger
Chief Financial Officer/Executive Vice President
Mark Stolper
Corporate Executive
Stephen Forthuber
Corporate Executive
Norman Hames
Executive Vice President - Finance/Chief Administrative Officer
Mital Patel
Executive Vice President/Chief Information Officer
Ranjan Jayanathan
Executive Vice President/General Counsel/Secretary
David Katz
Executive Vice President
Michael Murdock
Senior Vice President/Director of Human Resources/Director
Ruth Wilson
Senior Vice President
Christine Gordon
Vice President/Secretary/Director
John Crues
Lead Director/Independent Director
David Swartz
Independent Director
Laura Jacobs
Independent Director
Lawrence Levitt
No Data
No Data
About RDNT
RadNet, Inc., is a company, which is engaged in providing freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Company operates through joint ventures with hospitals, approximately 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Its centers provide physicians to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. In addition, it has a software division to facilitate imaging business. The Company through its subsidiary, eRAD, Inc. sales computerized systems that distribute, display, store and retrieve digital images.

Webull offers kinds of RadNet Inc. stock information, including NASDAQ:RDNT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RDNT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading RDNT stock methods without spending real money on the virtual paper trading platform.